Eastman Chemical (NYSE: EMN ) is expected to report Q2 earnings on July 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Eastman Chemical's revenues will increase 3.0% and EPS will shrink -5.8%.
The average estimate for revenue is $1.94 billion. On the bottom line, the average EPS estimate is $1.30.
Last quarter, Eastman Chemical logged revenue of $1.82 billion. GAAP reported sales were 3.6% higher than the prior-year quarter's $1.76 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.22. GAAP EPS of $1.12 for Q1 were 33% lower than the prior-year quarter's $1.66 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 23.7%, 240 basis points worse than the prior-year quarter. Operating margin was 15.0%, 290 basis points worse than the prior-year quarter. Net margin was 8.7%, 500 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $8.47 billion. The average EPS estimate is $5.17.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 186 members out of 211 rating the stock outperform, and 25 members rating it underperform. Among 52 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 49 give Eastman Chemical a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eastman Chemical is outperform, with an average price target of $57.06.
Can your retirement portfolio provide you with enough income to last? You'll need more than Eastman Chemical. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Eastman Chemical to My Watchlist.